Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: Biomarker substudy results from a prospective study with rivaroxaban (X-TRA).

CONCLUSIONS: Biomarkers of inflammation are significantly associated with LA/LAA thrombus outcomes in AF patients prospectively treated with rivaroxaban.
PMID: 29956554 [PubMed - as supplied by publisher]

Source: Annals of Medicine - July 1, 2018 Category: Internal Medicine Tags: Ann Med Source Type: research